Education
About Us
Working with TipRanks
Follow Us
Biosyent Inc (TSE:RX)
:RX
Total Valuation
Biosyent has a market cap or net worth of C$118.04M. The enterprise value is C$109.20M.
Market CapC$118.04M
Enterprise ValueC$109.20M
Share Statistics
Biosyent has 11,471,121 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding11,471,121
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Biosyent’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is 15.63%.
Return on Equity (ROE)0.19
Return on Assets (ROA)0.16
Return on Invested Capital (ROIC)15.63%
Return on Capital Employed (ROCE)0.21
Revenue Per Employee10.00T>
Profits Per Employee10.00T>
Employee Count―
Asset Turnover0.76
Inventory Turnover1.02
Valuation Ratios
The current PE Ratio of Biosyent is 16.56. Biosyent’s PEG ratio is 0.73.
PE Ratio16.56
PS Ratio3.74
PB Ratio3.08
Price to Fair Value3.08
Price to FCF21.91
Price to Operating Cash Flow21.16
PEG Ratio0.73
Income Statement
In the last 12 months, Biosyent had revenue of 31.59M and earned 6.46M in profits. Earnings per share was 0.54.
Revenue31.59M
Gross Profit25.60M
Operating Income7.47M
Pretax Income8.53M
Net Income6.46M
EBITDA9.06M
Earnings Per Share (EPS)0.54
Cash Flow
In the last 12 months, operating cash flow was 7.19M and capital expenditures -7.28M, giving a free cash flow of -87.30K billion.
Operating Cash Flow7.19M
Free Cash Flow-87.30K
Free Cash Flow per Share>-0.01
Dividends & Yields
Biosyent pays an annual dividend of C$0.185, resulting in a dividend yield of 1.8%
Dividend Per ShareC$0.185
Dividend Yield1.8%
Payout Ratio29.84%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.27
52-Week Price Change24.28%
50-Day Moving Average10.85
200-Day Moving Average10.80
Relative Strength Index (RSI)46.37
Average Volume (3m)4.61K
Important Dates
Biosyent upcoming earnings date is May 23, 2025, TBA Not Confirmed.
Last Earnings DateMar 13, 2025
Next Earnings DateMay 23, 2025
Ex-Dividend DateFeb 28, 2025
Financial Position
Biosyent as a current ratio of 6.48, with Debt / Equity ratio of 2.90%
Current Ratio6.48
Quick Ratio5.42
Debt to Market Cap0.00
Net Debt to EBITDA-0.75
Interest Coverage Ratio109.21
Taxes
In the past 12 months, Biosyent has paid 2.07M in taxes.
Income Tax2.07M
Effective Tax Rate0.24
Enterprise Valuation
Biosyent EV to EBITDA ratio is 11.06, with an EV/FCF ratio of 20.53.
EV to Sales3.17
EV to EBITDA11.06
EV to Free Cash Flow20.53
EV to Operating Cash Flow19.82
Balance Sheet
Biosyent has C$17.06M in cash and marketable securities with C$0.00 in debt, giving a net cash position of -C$15.98M billion.
Cash & Marketable SecuritiesC$17.06M
Total DebtC$0.00
Net Cash-C$15.98M
Net Cash Per Share-C$1.39
Tangible Book Value Per ShareC$2.81
Margins
Gross margin is 78.73%, with operating margin of 23.65%, and net profit margin of 20.45%.
Gross Margin78.73%
Operating Margin23.65%
Pretax Margin27.01%
Net Profit Margin20.45%
EBITDA Margin28.67%
EBIT Margin27.23%
Analyst Forecast
The average price target for Biosyent is C$11.75, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetC$11.75
Price Target Upside13.09% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast10.89%
EPS Growth Forecast16.21%